SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
NCT ID: NCT04497610
Last Updated: 2022-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2022-11-30
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of COVID-19 Using Breath Analysis - Validation Study
NCT04602949
Detection of COVID-19 Using Breath Analysis - Validation Study.
NCT05224622
Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.
NCT05094674
The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
NCT06571136
COVID Breath Test - Ancon
NCT04760639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel.
The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Positive TeraSystem test
Patients having positive PCR tests will undergo TeraSystem test
Breath sample
Patient will blow into a tube 5 times.
Negative TeraSystem test
Patients having negative PCR tests will undergo TeraSystem test
Breath sample
Patient will blow into a tube 5 times.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breath sample
Patient will blow into a tube 5 times.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
7 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Costarricense de Investigaciones Clínicas ICIC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Guillermo Rodríguez Gómez
Founder
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillermo Rodríguez Gómez, MD
Role: PRINCIPAL_INVESTIGATOR
Founder and Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Costarricense de Investigaciones Clínicas
San José, , Costa Rica
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tera-CR-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.